Lv6
2690 积分 2023-02-02 加入
First-Line Camizestrant for Emerging ESR1 -Mutated Advanced Breast Cancer
22小时前
待确认
First-Line Camizestrant for Emerging ESR1 -Mutated Advanced Breast Cancer
22小时前
已完结
Bone Imaging in Metastatic Breast Cancer
1个月前
已完结
First-Line Camizestrant for Emerging ESR1 -Mutated Advanced Breast Cancer
2个月前
已完结
Cardiac tamponade
3个月前
已完结
Precision treatment with artificial intelligence assisted subtyping enhances therapeutic efficacy in HR+/HER2− breast cancer: The LINUXtrial
3个月前
已完结
Pleural Effusion
3个月前
已完结
[Chinese expert consensus on treatment of malignant pleural effusion (2023 Edition)]
3个月前
已完结
Imlunestrant with or without Abemaciclib in Advanced Breast Cancer
3个月前
已完结
A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses
5个月前
已完结
皖公网安备34019202002308
